These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20938178)

  • 1. Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment.
    Johnson JK; Pa J; Boxer AL; Kramer JH; Freeman K; Yaffe K
    Dement Geriatr Cogn Disord; 2010; 30(4):344-51. PubMed ID: 20938178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course and etiology of dysexecutive MCI in a community sample.
    Huey ED; Manly JJ; Tang MX; Schupf N; Brickman AM; Manoochehri M; Mez J; DeCarli C; Devanand DP; Mayeux R
    Alzheimers Dement; 2013 Nov; 9(6):632-9. PubMed ID: 23452959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment.
    Aretouli E; Okonkwo OC; Samek J; Brandt J
    J Int Neuropsychol Soc; 2011 Mar; 17(2):277-88. PubMed ID: 21205413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysexecutive functioning in mild cognitive impairment: derailment in temporal gradients.
    Eppig J; Wambach D; Nieves C; Price CC; Lamar M; Delano-Wood L; Giovannetti T; Bettcher BM; Penney DL; Swenson R; Lippa C; Kabasakalian A; Bondi MW; Libon DJ
    J Int Neuropsychol Soc; 2012 Jan; 18(1):20-8. PubMed ID: 22014116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of atrophy differ among specific subtypes of mild cognitive impairment.
    Whitwell JL; Petersen RC; Negash S; Weigand SD; Kantarci K; Ivnik RJ; Knopman DS; Boeve BF; Smith GE; Jack CR
    Arch Neurol; 2007 Aug; 64(8):1130-8. PubMed ID: 17698703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment.
    Pa J; Boxer A; Chao LL; Gazzaley A; Freeman K; Kramer J; Miller BL; Weiner MW; Neuhaus J; Johnson JK
    Ann Neurol; 2009 Apr; 65(4):414-23. PubMed ID: 19399879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.
    Karas G; Sluimer J; Goekoop R; van der Flier W; Rombouts SA; Vrenken H; Scheltens P; Fox N; Barkhof F
    AJNR Am J Neuroradiol; 2008 May; 29(5):944-9. PubMed ID: 18296551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.
    Mez J; Cosentino S; Brickman AM; Huey ED; Manly JJ; Mayeux R
    PLoS One; 2013; 8(6):e65246. PubMed ID: 23755200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
    Korf ES; Wahlund LO; Visser PJ; Scheltens P
    Neurology; 2004 Jul; 63(1):94-100. PubMed ID: 15249617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semantic memory activation in amnestic mild cognitive impairment.
    Woodard JL; Seidenberg M; Nielson KA; Antuono P; Guidotti L; Durgerian S; Zhang Q; Lancaster M; Hantke N; Butts A; Rao SM
    Brain; 2009 Aug; 132(Pt 8):2068-78. PubMed ID: 19515831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.
    Hämäläinen A; Tervo S; Grau-Olivares M; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen R; Soininen H
    Neuroimage; 2007 Oct; 37(4):1122-31. PubMed ID: 17683950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests.
    Loewenstein DA; Acevedo A; Potter E; Schinka JA; Raj A; Greig MT; Agron J; Barker WW; Wu Y; Small B; Schofield E; Duara R
    Am J Geriatr Psychiatry; 2009 Dec; 17(12):1050-8. PubMed ID: 20104061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition.
    Schinka JA; Raj A; Loewenstein DA; Small BJ; Duara R; Potter H
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):266-74. PubMed ID: 19575419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.